Journal of Advances in Clinical Nursing

Objective To analyze the effectiveness of atorvastatin in the adjuvant treatment of hypertension with hyperlipidemia. Methods Sixty patients with hypertension and hyperlipidemia admitted to our hospital from January 2020 to January 2022 were selected as the research subjects. They were randomly divided into a control group and an observation group, with 30 cases in each group. The control group received routine treatment, while the observation group received adjuvant therapy with atorvastatin on top of the control group. Compare the differences in treatment effects between the two groups. Results The SBP and DBP in the observation group were significantly lower than those in the control group; The levels of TC, TG, LDL-C in the observation group were significantly lower than those in the control group, while the levels of HDL-C were significantly higher than those in the control group; The total effective rate of the observation group was significantly higher than that of the control group (P<0.05), indicating significant differences and statistical significance. Conclusion Atorvastatin has a significant therapeutic effect on hypertension combined with hyperlipidemia, and can effectively control blood lipids and blood pressure. It is worthy of clinical attention and vigorous promotion.

Atorvastatin; Hypertension; Hyperlipidemia; SBP; DBP